22.18
Introduction à l’hémostase
L’hémostase est un processus physiologique complexe qui empêche les saignements excessifs lorsqu’un vaisseau sanguin est blessé. Il est crucial pour l…
L’hémostase est une série de réactions défensives rapides déclenchées pour arrêter les saignements excessifs et favoriser la guérison après une lésion vasculaire.
Il s’agit d’une réponse très localisée régie par les facteurs de coagulation et les plaquettes qui ne commence qu’au site de la lésion.
Une blessure ou un traumatisme s’installe dans la phase vasculaire, où les vaisseaux sanguins se contractent rapidement pour réduire le flux sanguin.
La phase plaquettaire suit la vasoconstriction, où le collagène de la muqueuse cellulaire endothéliale endommagée initie l’adhésion plaquettaire.
Ces plaquettes localisées sont activées et libèrent plusieurs composés pour attirer plus de plaquettes, formant un bouchon plaquettaire lâche au site de la lésion. Ce processus est appelé agrégation plaquettaire.
De plus, les plaquettes libèrent également des facteurs de coagulation impliqués dans les réactions de la phase finale de coagulation.
Les facteurs de coagulation convertissent la protéine plasmatique fibrinogène en brins de fibrine insolubles, formant un réseau qui solidifie le bouchon plaquettaire en un caillot stable.
View the full transcript and gain access to JoVE Core videos
Q1: What happens to blood vessels immediately after an injury?
During the vascular phase, blood vessels quickly constrict in a process called vasoconstriction to reduce blood flow to the injury site. This rapid narrowing minimizes blood loss and is the first defensive response triggered by vascular injury, setting the stage for subsequent hemostasis phases.
Q2: How do platelets respond to a blood vessel injury?
Platelets adhere to exposed collagen from damaged endothelial cells and become activated. They then aggregate at the injury site, releasing compounds that attract additional platelets and clotting factors. This process forms a loose platelet plug that acts as a temporary seal to control bleeding.
Q3: What role do clotting factors play in hemostasis?
Clotting factors, including fibrinogen, are plasma proteins that convert into fibrin strands during the coagulation phase. These insoluble fibrin strands form a meshwork that solidifies the platelet plug into a stable clot, reinforcing the temporary seal and preventing further blood loss.
Q4: Why is hemostasis described as a localized response?
Hemostasis is highly localized because it is triggered only at the injury site and governed by clotting factors and platelets present in the immediate area. This targeted response prevents unnecessary clotting throughout the circulatory system while maintaining blood fluidity elsewhere in the vascular network.
Q5: What is the relationship between platelet aggregation and clot formation?
Platelet aggregation creates an initial loose plug at the injury site. Simultaneously, activated platelets release clotting factors that trigger the coagulation phase, converting fibrinogen to fibrin. This fibrin reinforces the platelet plug, transforming it into a stable, insoluble clot that effectively seals the vessel.
Q6: How does hemostasis maintain blood fluidity within intact vessels?
Hemostasis is a carefully controlled response that occurs only when vascular injury triggers the cascade. Under normal conditions, clotting factors remain inactive in plasma, and platelets circulate without aggregating. This balance ensures blood remains fluid and flows freely through the circulatory system until injury necessitates clot formation.
Q7: What are the three sequential phases of hemostasis?
Hemostasis progresses through three phases: the vascular phase involves vasoconstriction to reduce blood flow; the platelet phase includes platelet adhesion, activation, and aggregation forming a plug; and the coagulation phase converts fibrinogen to fibrin, creating a stable clot that reinforces the platelet plug and prevents further bleeding.